NEW YORK (GenomeWeb) – Abbott reported on Wednesday morning that its third quarter diagnostic revenues shrunk 2 percent year over year as its molecular diagnostics sales dropped 5 percent, both due to unfavorable currency effects.

The Abbott Park, Illinois-based company reported total worldwide revenues of $5.15 billion for the three months ended June 30, up 1 percent from $5.08 billion a year ago and edging out the Wall Street estimate of $5.14 billion. On an adjusted basis, excluding a nearly 10 percent foreign currency headwind, Q3 sales increased 11 percent, the company said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Five researchers are to share this year's Albany Medical Center Prize for their work on the CRISPR/Cas9 gene-editing tool, the AP reports.

Stat News reports on how white supremacists cope with surprising genetic ancestry testing results.

In Genome Research this week: sex-biased gene expression evolution in malaria mosquitos, method to find ancient selective sweeps, and more.

Iceland has nearly eliminated Down syndrome from its population, CBS News reports.